Assenagon Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History

Assenagon Asset Management’s Portfolio IOVA Stock Details IOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$195K	Hold	46,842	–	–	﹤0.01%	1142
2026 Q1	$164K	Hold	46,842	–	–	﹤0.01%	1079
2025 Q4	$128K	Hold	46,842	–	–	﹤0.01%	1128
2025 Q3	$102K	Hold	46,842	–	–	﹤0.01%	1150
2025 Q2	$80.6K	Hold	46,842	–	–	﹤0.01%	1139
2025 Q1	$156K	Sell	46,842 -1,700,035	-97%	-$8.77M	﹤0.01%	1121
2024 Q4	$12.9M	Buy	+1,746,877	New	+$16.2M	0.02%	446
2023 Q3	–	Sell	-32,047	Closed	-$226K	–	1420
2023 Q2	$226K	Hold	32,047	–	–	﹤0.01%	1271
2023 Q1	$196K	Sell	32,047 -7	-0%	-$48	﹤0.01%	1367
2022 Q4	$205K	Sell	32,054 -65	-0.2%	-$507	﹤0.01%	1311
2022 Q3	$308K	Hold	32,119	–	–	﹤0.01%	1200
2022 Q2	$355K	Sell	32,119 -82	-0.3%	-$1.07K	﹤0.01%	1296
2022 Q1	$536K	Hold	32,201	–	–	﹤0.01%	1192
2021 Q4	$615K	Sell	32,201 -1,425,107	-98%	-$31.4M	﹤0.01%	1160
2021 Q3	$35.9M	Sell	1,457,308 -22,411	-2%	-$528K	0.11%	150
2021 Q2	$38.5M	Buy	1,479,719 +1,443,340	+3,968%	+$37.5M	0.13%	140
2021 Q1	$1.15M	Buy	+36,379	New	+$1.51M	﹤0.01%	898

Other funds holding IOVA

MCP

Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

CWM

Centurion Wealth Management Mclean, Virginia $418M AUM 23.14% 1-Year Est. Return

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

TIA

Traphagen Investment Advisors Oradell, New Jersey $1.4B AUM 19.32% 1-Year Est. Return

Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Assenagon Asset Management's IOVA Position: Q2 2026 in Review

Assenagon Asset Management held its Iovance Biotherapeutics (IOVA) position steady in Q2 2026 at 46,842 shares worth $195K. The position accounts for ﹤0.01% of the portfolio, ranked #1142.

Assenagon Asset Management first reported a position in IOVA in Q1 2021 and has held it in 17 quarters since. The position peaked at $38.5M in Q2 2021. 19 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

Assenagon Asset Management held 46,842 shares of Iovance Biotherapeutics worth $195K as of Q2 2026.
Assenagon Asset Management left its Iovance Biotherapeutics share count unchanged in Q2 2026.
Iovance Biotherapeutics made up ﹤0.01% of Assenagon Asset Management's portfolio in Q2 2026, its #1142 holding.
Assenagon Asset Management first reported a position in Iovance Biotherapeutics in Q1 2021 and has held it in 17 quarters since.
Assenagon Asset Management's Iovance Biotherapeutics position peaked at $38.5M in Q2 2021.
19 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.